|
WO2020093084A1
|
|
Ventricular function determination
|
|
US2020069774A1
|
|
Treatment of obesity and eating disorders
|
|
EP3510172A1
|
|
Methods of detecting lentivirus
|
|
AU2008310310A1
|
|
A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
|
|
AU2008301240A1
|
|
A method for identifying antigen-specific regulatory T cells
|
|
AU2007202756A1
|
|
Anti-p53 antibodies
|
|
AU2005232335A1
|
|
Method for modulating appetite
|
|
AU2004281299A1
|
|
Assessment of disease risk by quantitative determination of epimutation in normal tissues
|
|
AU2004213066A1
|
|
Idiotypic vaccine
|
|
AU4901300A
|
|
Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
|
